Sector Alpha

Track where the smart money flows in Indian equities

DashboardWeekly UpdateUploadPipelinePE CyclesBrainAbout

Data updated weekly. Not financial advice.

Sector Alpha
  1. Home
  2. /Momentum
  3. /Hospitals
  4. /Artemis Medicare Services Ltd
MomentumDeep Value

Artemis Medicare Services Ltd: Stock Analysis & Fundamentals

Updated this week

Artemis Medicare Services Ltd (Hospitals) — fundamental analysis, earnings data, and key metrics. PE: 34.6. ROE: 12.9%. This stock is not currently in the Nifty 500 momentum outperformers list.

What's Happening

👔Promoter stake down 0.6% this quarter

Key Numbers

Current Price
₹216
Dividend Yield
0.21%
Market Cap
3.4K Cr
Valuation
N/A

Other Top Hospitals Stocks Beating Nifty 500

Apollo Hospitals Enterprise Ltd
Average • 6w streak
+17.1%
Aster DM Healthcare Ltd
Weak • 4w streak
+19.7%
KMC Speciality Hospitals (India) Ltd
Average • 12w streak
+15.5%
Sakar Healthcare Ltd
Average • 11w streak
+34.0%
← Back to HospitalsDashboard

Frequently Asked Questions: Artemis Medicare Services Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Artemis Medicare Services Ltd's latest quarterly results?

Artemis Medicare Services Ltd's latest quarterly results (Dec 2025) show

  • PAT Growth YoY: +4.8%
  • Revenue Growth YoY: +17.2%
  • Operating Margin: 16.0%

What is Artemis Medicare Services Ltd's current PE ratio?

Artemis Medicare Services Ltd's current PE ratio is 34.6x.

  • Current PE: 34.6x
  • Market Cap: 3.4K Cr
  • Dividend Yield: 0.21%

What is Artemis Medicare Services Ltd's price-to-book ratio?

Artemis Medicare Services Ltd's price-to-book ratio is 3.9x.

  • Price-to-Book (P/B): 3.9x
  • Book Value per Share: ₹56
  • Current Price: ₹216

Is Artemis Medicare Services Ltd a fundamentally strong company?

Artemis Medicare Services Ltd's fundamental strength based on key financial ratios

  • Return on Capital (ROCE): 15.0%

Is Artemis Medicare Services Ltd debt free?

Artemis Medicare Services Ltd has a debt-to-equity ratio of N/A.

  • Total Debt: ₹279 Cr

What is Artemis Medicare Services Ltd's return on equity (ROE) and ROCE?

Artemis Medicare Services Ltd's return ratios over recent years

  • FY2023: ROCE 11.0%
  • FY2024: ROCE 14.0%
  • FY2025: ROCE 15.0%

Is Artemis Medicare Services Ltd's cash flow positive?

Artemis Medicare Services Ltd's operating cash flow is positive (FY2025).

  • Cash from Operations (CFO): ₹146 Cr
  • Free Cash Flow (FCF): ₹-239 Cr
  • CFO/PAT Ratio: 178% (strong cash conversion)

What is Artemis Medicare Services Ltd's dividend yield?

Artemis Medicare Services Ltd's current dividend yield is 0.21%.

  • Dividend Yield: 0.21%
  • Current Price: ₹216

Who holds Artemis Medicare Services Ltd shares — promoters, FII, DII?

Artemis Medicare Services Ltd's shareholding pattern (Dec 2025)

  • Promoters: 58.4%
  • FII (Foreign): 12.5%
  • DII (Domestic): 2.9%
  • Public: 20.1%

Is promoter holding increasing or decreasing in Artemis Medicare Services Ltd?

Artemis Medicare Services Ltd's promoter holding has decreased recently.

  • Current Promoter Holding: 58.4% (Dec 2025)
  • Previous Quarter: 66.5% (Sep 2025)
  • Change: -8.15% (decreasing — worth monitoring)

Is Artemis Medicare Services Ltd a new momentum entry or an established outperformer?

Artemis Medicare Services Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.

Is Artemis Medicare Services Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Artemis Medicare Services Ltd may be worth studying

  • Cash flow is positive — CFO ₹146 Cr

What is the investment thesis for Artemis Medicare Services Ltd?

Artemis Medicare Services Ltd investment thesis summary:

What is the future outlook for Artemis Medicare Services Ltd?

Artemis Medicare Services Ltd's forward outlook based on current data signals

  • Insufficient data for a forward assessment — monitoring for more signals

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.